EPAM vs JBIO · P/E 14, rev $2.81B vs $868.2M cap
EPAM Systems Inc (EPAM) versus Jade Biosciences, Inc. (JBIO) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Jade Biosciences, Inc. (JBIO) is a biotechnology company listed on US.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
JBIO does not have a complete income-statement cache yet.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. JBIO currently screens at market cap $868.2M.
Not investment advice. Open the EPAM and JBIO stock pages for the full models.
Not investment advice.